Showing results (281-290 of 348) with videos related to

Sort By:
Pageof 35
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2009
The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trialsI Chau, A R Norman, D Cunningham, et al.
ACS Omega|March 29, 2021
Hierarchical Lignin-Based Carbon Matrix and Carbon Dot Composite Electrodes for High-Performance SupercapacitorsLu Yu, Chien-Te Hsieh, David J Keffer, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 20, 1998
Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated?J P Heggers, C Villarreal, P Edgar, et al.
Proceedings (Baylor University. Medical Center)|May 6, 2021
ANCA-associated vasculitis and severe proximal muscle weaknessJordan S Dutcher, Albert Bui, Tochukwu A Ibe, et al.
American Journal of Human Genetics|February 1, 1997
Sequence variation at the phenylalanine hydroxylase gene in the British IslesL A Tyfield, A Stephenson, F Cockburn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology GroupM Gore, P Mainwaring, R A'Hern, et al.
Science Advances|April 26, 2017
Adaptive foveated single-pixel imaging with dynamic supersamplingDavid B Phillips, Ming-Jie Sun, Jonathan M Taylor, et al.
Optics Letters|January 26, 2011
Effect of Rayleigh-scattering distributed feedback on multiwavelength Raman fiber laser generationA E El-Taher, P Harper, S A Babin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2006
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trialsM Trumper, P J Ross, D Cunningham, et al.
British Journal of Cancer|July 7, 2005
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trialG M Mead, M H Cullen, R Huddart, et al.
Pageof 35